Nai-Kong V. Cheung
Department of Pediatrics
Memorial Sloan-Kettering Cancer Center
New York
NY 10065;
Name/email consistency: high
- Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission. Cheung, N.K., Cheung, I.Y., Kushner, B.H., Ostrovnaya, I., Chamberlain, E., Kramer, K., Modak, S. J. Clin. Oncol. (2012)
- FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor. Cheung, N.K., Sowers, R., Vickers, A.J., Cheung, I.Y., Kushner, B.H., Gorlick, R. J. Clin. Oncol. (2006)
- Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2. Cheung, N.K., Modak, S., Lin, Y., Guo, H., Zanzonico, P., Chung, J., Zuo, Y., Sanderson, J., Wilbert, S., Theodore, L.J., Axworthy, D.B., Larson, S.M. J. Nucl. Med. (2004)
- Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapy. Cheung, N.K., Guo, H.F., Modak, S., Cheung, I.Y. Hybrid. Hybridomics (2003)
- Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma. Cheung, N.K., Modak, S. Clin. Cancer Res. (2002)
- Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cheung, N.K., Modak, S., Vickers, A., Knuckles, B. Cancer Immunol. Immunother. (2002)
- Anti-idiotypic antibody as the surrogate antigen for cloning scFv and its fusion proteins. Cheung, N.K., Guo, H.F., Modak, S., Cheung, I.Y. Hybrid. Hybridomics (2002)
- Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE. Cheung, I.Y., Cheung, N.K. Med. Pediatr. Oncol. (2001)
- N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Cheung, N.K., Kushner, B.H., LaQuaglia, M., Kramer, K., Gollamudi, S., Heller, G., Gerald, W., Yeh, S., Finn, R., Larson, S.M., Wuest, D., Byrnes, M., Dantis, E., Mora, J., Cheung, I.Y., Rosenfield, N., Abramson, S., O'Reilly, R.J. Med. Pediatr. Oncol. (2001)
- Monoclonal antibody-based therapy of neuroblastoma. Cheung, N.K., Kushner, B.H., Kramer, K. Hematol. Oncol. Clin. North Am. (2001)
- Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma. Cheung, N.K., Guo, H.F., Heller, G., Cheung, I.Y. Clin. Cancer Res. (2000)
- Correlation of anti-idiotype network with survival following anti-G(D2) monoclonal antibody 3F8 therapy of stage 4 neuroblastoma. Cheung, N.K., Guo, H.F., Cheung, I.Y. Med. Pediatr. Oncol. (2000)
- Monoclonal antibody-based therapy for neuroblastoma. Cheung, N.K. Curr. Oncol. Rep (2000)
- Detection of neuroblastoma in bone marrow by immunocytology: is a single marrow aspirate adequate?. Cheung, N.K., Heller, G., Kushner, B.H., Kramer, K. Med. Pediatr. Oncol. (1999)
- Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. Cheung, N.K., Kushner, B.H., Cheung, I.Y., Kramer, K., Canete, A., Gerald, W., Bonilla, M.A., Finn, R., Yeh, S.J., Larson, S.M. J. Clin. Oncol. (1998)
- Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?. Cheung, N.K., Heller, G., Kushner, B.H., Liu, C., Cheung, I.Y. J. Clin. Oncol. (1997)
